October 11, 2023 — GE HealthCare today announced an exclusive global licensing agreement with SOFIE Biosciences (SOFIE) ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
October 11, 2023 — A new imaging agent, 68Ga-ABY-025, can predict early metabolic response to human epidermal growth ...
October 5, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
September 28, 2023 — RefleXion Medical, a therapeutic oncology company, announced the company will showcase the ...
Since the advent of the magnetic resonance imaging (MRI) exam on human patients in the late 1970s, this innovation ...
September 21, 2023 — Scientists in Moscow have successfully engineered a prototype detector for X-ray and PET/CT ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
September 8, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce ...
September 7, 2023 — The groundbreaking AURA 10 specimen imager by Belgian MedTech pioneer XEOS has been cleared by the ...
According to a new report from Transparency Market Research (TMR), PET radiotracers are expected to rise at a CAGR of 8 ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
August 15, 2023 — In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid ...
The healthcare industry faces many different types of obstacles in today’s challenging marketplace. Staff shortages ...
July 28, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
July 27, 2023 — Scientists have found a new use for copper in magnetic resonance imaging (MRI) contrast agent design ...
July 26, 2023 — A molecular imaging tool developed by researchers at the University of California’s two nationally ...
July 25, 2023 — Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative ...
July 25, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce that ...
July 12, 2023 — United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment and ...
The healthcare market is witnessing a dynamic shift in how and where patients want to receive care, with the flexibility ...
July 11, 2023 — Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative ...
July 3, 2023 — RefleXion Medical, Inc., a therapeutic oncology company, today announced that results of a prospective ...